Evidence map›Paper›PMID 38985991›Full record

ArticleDiabetes2024

Electrophysiological Characterization of Inducible Pluripotent Stem Cell-Derived Human β-Like Cells and an SLC30A8 Disease Model.

Manon Jaffredo, Nicole A J Krentz, Benoite Champon, Claire E Duff, Sameena Nawaz, Nicola Beer, Christian Honore, Anne Clark, Patrik Rorsman, Jochen Lang and 3 more

Abstract read
In one paragraph

Article in Diabetes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Postnatal refinement of CaChannels (Austin, Tex.) · 2026
    Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Manon JaffredoUniversity of Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, Pessac, France.
Nicole A J KrentzWellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, U.K.
Benoite ChamponWellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, U.K.
Claire E DuffWellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, U.K.
Sameena NawazOxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, U.K.
Nicola BeerOxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, U.K.
Christian HonoreCell Therapy R&D, Novo Nordisk A/S, Måløv, Denmark.
Anne ClarkOxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, U.K.ORCID 0000-0001-5007-3513
Patrik RorsmanOxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, U.K.
Jochen LangUniversity of Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, Pessac, France.ORCID 0000-0001-6847-5641
Anna L GloynWellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, U.K.ORCID 0000-0003-1205-1844
Matthieu RaouxUniversity of Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, Pessac, France.ORCID 0000-0001-8791-2034
Benoit HastoyOxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, U.K.ORCID 0000-0003-1244-7857

Funding

Bridging the gap between type 2 diabetes GWAS and therapeutic targetsUM1DK126185 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CLAUSSNITZER, MELINA C, GLOYN, ANNA LOUISE · 2020 to 2024
$9.5M
Agence Nationale de la Recherche 18-CE17-0005Diabetes UK 19/0005965European Foundation for the Study of Diabetes Albert Renold awardKing Abdulaziz University & Oxford University Centre for Artificial Intelligence in Precision Medicines (KO-CAIPM)NIDDK NIH HHS UM1 DK126185NIH HHS UM-1DK126185Wellcome Trust 200837Wellcome Trust 200837/Z/16/Z
6 · The paper itself

Abstract

Inducible pluripotent stem cell-derived human β-like cells (BLCs) hold promise for both therapy and disease modeling, but their generation remains challenging and their functional analyses beyond transcriptomic and morphological assessments remain limited. Here, we validate an approach using multicellular and single-cell electrophysiological tools to evaluate function of BLCs from pioneer protocols that can be easily adapted to more differentiated BLCs. The multi-electrode arrays (MEAs) measuring the extracellular electrical activity revealed that BLCs, like primary β-cells, are electrically coupled and produce slow potential (SP) signals that are closely linked to insulin secretion. We also used high-resolution single-cell patch clamp measurements to capture the exocytotic properties, and characterize voltage-gated sodium and calcium currents, and found that they were comparable with those in primary β- and EndoC-βH1 cells. The KATP channel conductance is greater than in human primary β-cells, which may account for the limited glucose responsiveness observed with MEA. We used MEAs to study the impact of the type 2 diabetes-protective SLC30A8 allele (p.Lys34Serfs50*) and found that BLCs with this allele have stronger electrical coupling activity. Our data suggest that BLCs can be used to evaluate the functional impact of genetic variants on β-cell function and coupling. ARTICLE HIGHLIGHTS:

Indexed as

Induced Pluripotent Stem CellsInsulin-Secreting CellsZinc Transporter 8Cell DifferentiationDiabetes Mellitus, Type 2Electrophysiological PhenomenaHumansPatch-Clamp TechniquesSLC30A8 protein, humanZinc Transporter 8

Identifiers

PMID38985991
PMCPMC11262041

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.